Cart
sales@molnova.com
Sovaprevir
CAS No. 1001667-23-7
Sovaprevir( ACH-1625 | ACH1625 | ACH-0141625 )
Catalog No. M10021 CAS No. 1001667-23-7
Sovaprevir (ACH-1625, ACH-0141625) is a potent HCV NS3/4A inhibitor in development for the treatment of hepatitis C.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 1036 | In Stock |
|
| 5MG | 655 | In Stock |
|
| 10MG | 934 | In Stock |
|
| 25MG | 1387 | In Stock |
|
| 50MG | 1832 | In Stock |
|
| 100MG | 2465 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSovaprevir
-
NoteResearch use only, not for human use.
-
Brief DescriptionSovaprevir (ACH-1625, ACH-0141625) is a potent HCV NS3/4A inhibitor in development for the treatment of hepatitis C.
-
DescriptionSovaprevir (ACH-1625, ACH-0141625) is a potent HCV NS3/4A inhibitor in development for the treatment of hepatitis C.HCV Infection Phase 2 Clinical
-
In Vitro——
-
In Vivo——
-
SynonymsACH-1625 | ACH1625 | ACH-0141625
-
PathwayMicrobiology/Virology
-
TargetHCV
-
RecptorHCV
-
Research AreaInfection
-
IndicationHCV Infection
Chemical Information
-
CAS Number1001667-23-7
-
Formula Weight799.984
-
Molecular FormulaC43H53N5O8S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C([C@H]1N(C([C@@H](CC(N2CCCCC2)=O)C(C)(C)C)=O)C[C@H](OC3=CC(C4=CC=CC=C4)=NC5=CC(OC)=CC=C35)C1)N[C@@]6(C(NS(=O)(C7CC7)=O)=O)[C@H](C=C)C6
-
Chemical Name2-Pyrrolidinecarboxamide,N-[(1R,2S)-1-[[(cyclopropylsulfonyl)amino]carbonyl]-2-ethenylcyclopropyl]-1-[(2S)-3,3-dimethyl-1-oxo-2-[2-oxo-2-(1-piperidinyl)ethyl]butyl]-4-[(7-methoxy-2-phenyl-4-quinolinyl)oxy]-, (2S,4R)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Nakamoto S, et al. World J Gastroenterol. 2014 Mar 21;20(11):2902-12.
molnova catalog
related products
-
CEP37440
CEP-37440 is an effective and specific Dual FAK/ALK inhibitor with IC50s of 120 nM(ALK cellular in 75% human plasma) and 2.3 nM (FAK).
-
Ravidasvir
Ravidasvir (PPI-668;BI 238630) is a potent pan-genotypic HCV NS5A inhibitor with IC50 of 0.12/0.01/1.14 nM for HCV gt-1a/1b/3a in replicon luciferase assay.
-
Glecaprevir
Glecaprevir (ABT 493;A 1282576) is a novel HCV NS3/4A protease inhibitor with pan-genotypic activity, inhibits NS3/4A proteases from HCV genotypes 1-6 in vitro with IC50 of 3.5-11.3 nM.
